Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > AGM Date: June 29, 2023

<< Previous

Bullboard Posts

Next >>

Comment by Yajneon Apr 25, 2023 11:12am

202 Views

Post# 35412406

RE:RE:RE:RE:RE:RE:AGM Date: June 29, 2023

TSX year-end reporting deadline for venture-based companies this year is May 1 (Apr 30 is on w/e). TLT has often filed their YE financials a day or two early, and IMO will do so this year as well so trial update is released before AUA meeting. IMO we'll see that NR at latest on Thurs this week since Fri NR's are usually a 'no-no' for good news.

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals